Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
26 January 2024 | Story Charlene Stanley | Photo Supplied
Mother tongue pride
UFS staff members and students celebrating learners’ achievements at the Philippolis Public Speaking Competition. Pictured are Jani de Lange and Likiledi Mokoena; back: Lusenda Machini, Kevin Cloete, Susan Lombaard, Tinotenda Magaya, and Mabatho Ntsieng.

A unique public speaking competition hosted in the small town of Philippolis has done wonders to not only build confidence in young mother tongue speakers, but to broaden the cultural perspectives of an entire community.

The Philippolis Public Speaking Competition has been hosted by the Unit for Language Facilitation and Empowerment (ULFE) and the Department of Community Engagement (CE) at the University of the Free State (UFS) since 2013. What started as a small competition for learners in this Southern Free State town, has grown into a much-anticipated annual event, drawing participants from schools in neighbouring towns such as Trompsburg, Bethulie, Jagersfontein, Fauresmith, Gariepdam, and Reddersburg.

Talking about heritage

Every year, learners from Grades 6 to 9 are invited to present a speech on a specific heritage-related topic. Participants are encouraged to speak in their mother tongues – which in this region are mainly Afrikaans, Sesotho, Setswana, and isiXhosa.

Interpreters from the UFS ULFE ensure that the audience can follow each speech. For the past few years, deaf learners from the Bartimea School for the Deaf and Blind in Thaba Nchu and Re Tlameleng School for the Deaf in Kimberley have made welcome appearances, assisted by UFS sign language interpreters.

“This is a wonderful opportunity to teach our young people about acknowledging and respecting different opinions – but also to consider perspectives from differently abled individuals,” enthuses Anita Muller, a teacher from Bergmanshoogte Primary School, who has been involved in the competition from the very beginning.

“Learners in rural areas so often believe they don’t have a voice, and that nobody is interested in their opinions,” she continues.

“This competition does wonderful work in building feelings of self-worth and self-confidence. And it is usually a welcome opportunity for our broader community to get together, learn about one another’s cultures, and change perspectives.” 

Embracing individuality

Jani de Lange, UFS Lecturer in South African Sign Language and Deaf Studies, and one of the coordinators of the project, says she was excited to note that the master of ceremonies of last year’s competition was a former participant in the very first event.

“This project gives me a sense of pride and reminds me why I am part of the UFS. It has been a real eye-opener to see how important it is for those involved,” she says.

“It encourages our young people to embrace their individuality, as we celebrate the cultures and traditions of all those who participate,” says Mabatho Ntsieng from the Engaged Scholarship Office. She says young people often lose sight of where they come from. By giving them opportunities to research topics linked to their heritage and then present their speech in their mother tongue, they can return to their cultural roots.

“It is wonderful to see how proud these participants are and the impact it has on the schools and the community.”

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept